Phase IIB Dose Response and Safety Study of Topical Formulations of Methotrexate (MQX-5902, MQX-5904 and MQX-5906) in the Treatment of Fingernail Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2016
At a glance
- Drugs Methotrexate (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 27 Apr 2016 Status changed from active, no longer recruiting to completed.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2006-004346-17).
- 09 Oct 2009 New trial record.